Bilateral breast cancers

Perceptions, Knowledge, and Satisfaction With Contralateral Prophylactic Mastectomy Among Young Women With Breast Cancer

(2013) Shoshana M. Rosenberg et al.   ANNALS OF INTERNAL MEDICINE

Contralateral mastectomy improves survival in women with BRCA1/2-associated breast cancer

(2013) D. Gareth R. Evans et al.   BREAST CANCER RESEARCH AND TREATMENT

Clinical implications of genetic testing for BRCA1 and BRCA2 mutations in Austria

(2013) CF Singer et al.   CLINICAL GENETICS

Rates of risk-reducing surgery in IsraeliBRCA1andBRCA2mutation carriers

(2013) Y Laitman et al.   CLINICAL GENETICS

Tamoxifen and Risk of Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers

(2013) Kelly-Anne Phillips et al.   JOURNAL OF CLINICAL ONCOLOGY

Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE

(2013) Nasim Mavaddat et al.   JNCI-Journal of the National Cancer Institute

Contralateral risk-reducing mastectomy in sporadic breast cancer

(2013) John A Murphy et al.   LANCET ONCOLOGY

Global Changes in the Mammary Epigenome Are Induced by Hormonal Cues and Coordinated by Ezh2

(2013) Bhupinder Pal et al.   Cell Reports

Estrogen receptor, progesterone receptor, and HER2-neu expression in first primary breast cancers and risk of second primary contralateral breast cancer

(2012) Babette Siebold Saltzman et al.   BREAST CANCER RESEARCH AND TREATMENT

Association between contralateral prophylactic mastectomy and breast cancer outcomes by hormone receptor status

(2012) Abenaa M. Brewster et al.   CANCER

Risk of Asynchronous Contralateral Breast Cancer in Noncarriers ofBRCA1andBRCA2Mutations With a Family History of Breast Cancer: A Report From the Women's Environmental Cancer and Radiation Epidemiology Study

(2012) Anne S. Reiner et al.   JOURNAL OF CLINICAL ONCOLOGY

Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer

(2012) Elise Ruark et al.   NATURE

Breast cancer in young women

(2012) Steven A. Narod   Nature Reviews Clinical Oncology

Occult Malignancy in Patients Undergoing Contralateral Prophylactic Mastectomy

(2011) Tari A. King et al.   ANNALS OF SURGERY

The impact of contralateral mastectomy on mortality in BRCA1 and BRCA2 mutation carriers with breast cancer

(2011) Steven A. Narod   BREAST CANCER RESEARCH AND TREATMENT

Body mass index and risk of second primary breast cancer: The WECARE Study

(2011) Jennifer D. Brooks et al.   BREAST CANCER RESEARCH AND TREATMENT

Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers

(2011) K Metcalfe et al.   BRITISH JOURNAL OF CANCER

Risk of a Second Breast Cancer Associated with Hormone-Receptor and HER2/neu Status of the First Breast Cancer

(2011) L. Bessonova et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

When is contralateral mastectomy warranted in unilateral breast cancer?

(2011) Mitchel Barry et al.   Expert Review of Anticancer Therapy

Clinical Management Factors Contribute to the Decision for Contralateral Prophylactic Mastectomy

(2011) Tari A. King et al.   JOURNAL OF CLINICAL ONCOLOGY

Paired distribution of molecular subtypes in bilateral breast carcinomas

(2011) Hege G. Russnes et al.   Cancer Genetics

Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer

(2010) Kerryn W. Reding et al.   BREAST CANCER RESEARCH AND TREATMENT

Concordance in histological and biological parameters between first and second primary breast cancers

(2010) Dezheng Huo et al.   CANCER

Reproductive factors and risk of contralateral breast cancer by BRCA1 and BRCA2 mutation status: results from the WECARE study

(2010) Jenny N. Poynter et al.   CANCER CAUSES & CONTROL

Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing Breast Cancer

(2010) V. G. Vogel et al.   Cancer Prevention Research

Testing for CHEK2 in the cancer genetics clinic: ready for prime time?

(2010) SA Narod   CLINICAL GENETICS

Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality

(2010) Susan M. Domchek   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Population-Based Study of the Risk of Second Primary Contralateral Breast Cancer Associated With Carrying a Mutation inBRCA1orBRCA2

(2010) Kathleen E. Malone et al.   JOURNAL OF CLINICAL ONCOLOGY

Population-Based Study of Contralateral Prophylactic Mastectomy and Survival Outcomes of Breast Cancer Patients

(2010) I. Bedrosian et al.   JNCI-Journal of the National Cancer Institute

Alcohol Intake and Cigarette Smoking and Risk of a Contralateral Breast Cancer: The Women's Environmental Cancer and Radiation Epidemiology Study

(2009) J. A. Knight et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Pathological and molecular characteristics distinguishing contralateral metastatic from new primary breast cancer

(2009) B. Banelli et al.   ANNALS OF ONCOLOGY

Early detection of second breast cancers improves prognosis in breast cancer survivors

(2009) N. Houssami et al.   ANNALS OF ONCOLOGY

Diagnostic Breast Magnetic Resonance Imaging and Contralateral Prophylactic Mastectomy

(2009) Melony E. S. Sorbero et al.   ANNALS OF SURGICAL ONCOLOGY

An investigation into the performance of the Adjuvant! Online prognostic programme in early breast cancer for a cohort of patients in the United Kingdom

(2009) H E Campbell et al.   BRITISH JOURNAL OF CANCER

Mammographic density and the risk of breast cancer recurrence after breast-conserving surgery

(2009) Tulin Cil et al.   CANCER

Tumor Self-Seeding by Circulating Cancer Cells

(2009) Mi-Young Kim et al.   CELL

Tamoxifen reduces the risk of contralateral breast cancer in premenopausal women: Results from a controlled randomised trial

(2009) Sara Alkner et al.   EUROPEAN JOURNAL OF CANCER

Polygenic susceptibility to breast cancer: current state-of-the-art

(2009) Maya Ghoussaini et al.   Future Oncology

Magnetic Resonance Imaging Screening of the Contralateral Breast in Women With Newly Diagnosed Breast Cancer: Systematic Review and Meta-Analysis of Incremental Cancer Detection and Impact on Surgical Management

(2009) Meagan Elizabeth Brennan et al.   JOURNAL OF CLINICAL ONCOLOGY

Contralateral Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

(2009) Monika K. Graeser et al.   JOURNAL OF CLINICAL ONCOLOGY

Second Primary Breast Cancer Occurrence According to Hormone Receptor Status

(2009) A. W. Kurian et al.   JNCI-Journal of the National Cancer Institute

Risk for contralateral breast cancer among carriers of the CHEK2*1100delC mutation in the WECARE Study

(2008) L Mellemkjær et al.   BRITISH JOURNAL OF CANCER

TP53 mutations in synchronous and metachronous bilateral breast carcinomas

(2008) Evgeny N. Suspitsin et al.   CANCER GENETICS AND CYTOGENETICS

Frequency of the CHEK2 1100delC Mutation among Women with Breast Cancer: An International Study

(2008) S. Zhang et al.   CANCER RESEARCH

International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers

(2008) Kelly A. Metcalfe et al.   INTERNATIONAL JOURNAL OF CANCER

Oral Contraceptives, Postmenopausal Hormones, and Risk of Asynchronous Bilateral Breast Cancer: The WECARE Study Group

(2008) Jane C. Figueiredo et al.   JOURNAL OF CLINICAL ONCOLOGY

Relationship of Breast Magnetic Resonance Imaging to Outcome After Breast-Conservation Treatment With Radiation for Women With Early-Stage Invasive Breast Carcinoma or Ductal Carcinoma in Situ

(2008) Lawrence J. Solin et al.   JOURNAL OF CLINICAL ONCOLOGY